UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Papassotiropoulos, A; Lambert, J C; Wavrant-De Vrièze, F; Wollmer, M A; von der Kammer, H; Streffer, J R; Maddalena, A; Huynh, K D; Wolleb, S; Lütjohann, D; Schneider, B; Thal, D R; Grimaldi, L M E; Tsolaki, M; Kapaki, E; Ravid, R; Konietzko, U; Hegi, T; Pasch, T; Jung, H; Braak, H; Amouyel, P; Rogaev, E I; Hardy, J; Hock, C; Nitsch, R M (2005). Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease. Neurodegenerative Diseases, 2(5):233-241.

de Quervain, D J F; Poirier, R; Wollmer, M A; Grimaldi, L M E; Tsolaki, M; Streffer, J R; Hock, C; Nitsch, R M; Mohajeri, M H; Papassotiropoulos, A (2004). Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Human Molecular Genetics, 13(1):47-52.

Götz, J; Streffer, J R; David, D; Schild, A; Hoerndli, F; Pennanen, L; Kurosinski, P; Chen, F (2004). Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Molecular Psychiatry, 9(7):664-683.

Wollmer, M A; Streffer, J R; Lütjohann, D; Tsolaki, M; Iakovidou, V; Hegi, T; Pasch, T; Jung, H H; von Bergmann, K; Nitsch, R M; Hock, C; Papassotiropoulos, A (2003). ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiology of Aging, 24(3):421-426.

Hock, C; Konietzko, U; Streffer, J R; Tracy, J; Signorell, A; Müller-Tillmanns, B; Lemke, U; Henke, K; Moritz, E; Garcia, E; Wollmer, M A; Umbricht, D; de Quervain, D J F; Hofmann, M; Maddalena, A; Papassotiropoulos, A; Nitsch, R M (2003). Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron, 38(4):547-554.

Wollmer, M A; Streffer, J R; Tsolaki, M; Grimaldi, L M E; Lütjohann, D; Thal, D; von Bergmann, K; Nitsch, R M; Hock, C; Papassotiropoulos, A (2003). Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Molecular Psychiatry, 8(6):635-638.

Papassotiropoulos, A; Streffer, J R; Tsolaki, M; Schmid, S; Thal, D; Nicosia, F; Iakovidou, V; Maddalena, A; Lütjohann, D; Ghebremedhin, E; Hegi, T; Pasch, T; Träxler, M; Brühl, A; Benussi, L; Binetti, G; Braak, H; Nitsch, R M; Hock, C (2003). Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Archives of Neurology, 60(1):29-35.

Streffer, J R; Papassotiropoulos, A; Kurosinski, P; Signorell, A; Wollmer, M A; Tsolaki, M; Iakovidou, V; Hörndli, F; Bosset, J; Götz, J; Nitsch, R M; Hock, C (2003). Saitohin gene is not associated with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74(3):362-363.

Wollmer, M A; Papassotiropoulos, A; Streffer, J R; Grimaldi, L M E; Kapaki, E; Salani, G; Paraskevas, G P; Maddalena, A; de Quervain, D; Bieber, C; Umbricht, D; Lemke, U; Bosshardt, S; Degonda, N; Henke, K; Hegi, T; Jung, H H; Pasch, T; Hock, C; Nitsch, R M (2002). Genetic polymorphisms and cerebrospinal fluid levels of tissue inhibitor of metalloproteinases 1 in sporadic Alzheimer's disease. Psychiatric Genetics, 12(3):155-160.

Glatzel, M; Rogivue, C; Ghani, A; Streffer, J R; Amsler, L; Aguzzi, A (2002). Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet, 360(9327):139-141.

This list was generated on Fri Jul 21 05:31:04 2017 CEST.